Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: Reliability of home testing

Human Reproduction

Volumn 27, Issue 2, 2012, Pages 550-557

  Blackwell, Leonard F ^a   Vigil, Pilar ^b   Gross, Barbara ^e   D'Arcangues, Catherine ^c   Cooke, Delwyn G ^d   Brown, James B ^e  

^a MASSEY UNIVERSITY   (New Zealand)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d Manawatu Diagnostics   (New Zealand)

^e NONE

Author keywords

estrone glucuronide; menstrual cycle profiles; pre coated tubes; pregnanediol glucuronide; urine home test

Indexed keywords

ESTRONE GLUCURONIDE; GLUCURONIDE; PREGNANEDIOL; PREGNANEDIOL GLUCURONIDE; UNCLASSIFIED DRUG;

ARTICLE; AUSTRALIA; CHILE; FEMALE; HOME MONITORING; HUMAN; INFORMATION PROCESSING; MEASUREMENT; MENSTRUAL CYCLE; NEW ZEALAND; OVARY FUNCTION; QUALITY CONTROL; SYSTEMATIC ERROR; URINARY EXCRETION;

EID: 84862922498     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der409     Document Type: Article

References (23)

1. Alliende ME. Mean versus individual hormonal profiles in the menstrual cycle. Fertil Steril 2002;78:90-95.
2. Baerwald AR, Adams GP, Pierson RA. A new model for ovarian follicular development during the human menstrual cycle. Fertil Steril 2003a; 80:116-122.
3. Baerwald AR, Adams GP, Pierson RA, Baerwald AR, Adams GP, Pierson RA. Characterization of ovarian follicular wave dynamics in women. Biol Reprod 2003b; 69:1023-1031.
4. Blackwell LF, Brown JB. Application of time-series analysis for the recognition of increases in urinary estrogens as markers for the beginning of the potentially fertile period. Steroids 1992;57:554-562.
5. Blackwell LF, Brown JB, Cooke D. Definition of the potentially fertile period from urinary steroid excretion rates. Part II. A threshold value for pregnanediol glucuronide as a marker for the end of the potentially fertile period in the human menstrual cycle. Steroids 1998;63:5-13.
6. Blackwell LF, Brown JB, Vigil P, Gross B, Sufi S, d'Arcangues C. Hormonal monitoring of ovarian activity using the Ovarian Monitor, part I. Validation of home and laboratory results obtained during ovulatory cycles by comparison with radioimmunoassay. Steroids 2003;68:465-476.
7. Brown JB. Types of ovarian activity in women and their significance: the Continuum (a reinterpretation of early findings). Hum Reprod Update 2011;17:141-158.
8. Brown JB, Blackwell LF, Cox RI, Holmes JM, Smith MA. Chemical and homogeneous enzyme immunoassay methods for the measurement of estrogens and pregnanediol and their glucuronides in urine. Prog Clin Biol Res 1988;285:119-138.
9. Brown JB, Blackwell LF, Holmes J, Smyth K. New assays for identifying the fertile period. Int J Gynecol Obstet-Suppl 1989;1:111-122.
10. Brown JB, Holmes J, Barker G. Use of the Home Ovarian Monitor in pregnancy avoidance. Am J Obstet Gynecol 1991;165:2008-2011.
11. Cavero C. Using an ovarian monitor as an adjunct to natural family planning. J Nurse Midwifery 1995;40:269-276.
12. Cole LA, Ladner DG, Byrn FW. The normal variabilities of the menstrual cycle. Fertil Steril 2009;91:522-527.
13. Collins WP. Biochemical indices of potential fertility. Suppl Int J Gynecol Obstet 1989;1:35-43.
14. Cooke DG, Binnie JE, Blackwell LF. Validation of a reference ELISA for estrone glucuronide using urine samples normalized by dilution to a constant rate of urine production. Steroids 2007;72:580-591.
15. Ecochard R, Boehringer H, Rabilloud M, Marret H. Chronological aspects of ultrasonic, hormonal, and other indirect indices of ovulation. Int J Obstet Gynaecol 2001;108:822-829.
16. Freundl G, Sivin I, Batar I. State-of-the-art of non-hormonal methods of contraception: IV. Natural family planning. Eur J Contracept Reprod Health Care 2010;15:113-123.
17. Gore MA, Nayudu PL, Vlaisavljevic V, Thomas N. Prediction of ovarian cycle outcome by follicular characteristics, stage 1. Hum Reprod 1995;10:2313-2319.
18. Krieg EF Jr, Kesner JS, Knecht EA. An algorithm for detecting features of the hormone profiles of the human menstrual cycle. Comput Biol Med 1999;29:229-242.
19. Krotz S, McKenzie LJ, Cisneros P, Buster J, Amato P, Carson S, Krotz S, McKenzie LJ, Cisneros P, Buster J et al. Prevalence of premature urinary luteinizing hormone surges in women with regular menstrual cycles and its effect on implantation of frozen-thawed embryos. Fertil Steril 2005;83:1742-1744.
20. Moghissi KS, Syner FN, Evans TN. A composite picture of the menstrual cycle. Am J Obstet Gynecol 1972;114:405-418.
21. Munro CJ, Stabenfeldt GH, Cragun JR, Addiego LA, Overstreet JW, Lasley BL. Relationship of serum estradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay. Clin Chem 1991;37:838-844.
22. Santoro N, Isaac B, Neal-Perry G, Adel T, Weingart L, Nussbaum A, Thakur S, Jinnai H, Khosla N, Barad D et al. Impaired folliculogenesis and ovulation in older reproductive aged women. J Clin Endocrinol Metab 2003;88:5502-5509.
23. Snedecor GW, Cochran WG. Statistical Methods. Iowa, USA: Wiley-Blackwell, 1989.